重症筋無力症の抗原特異的免疫吸着療法 II アセチルコリン受容体合成ペプチドの病的免疫原性検定とその臨床応用
書誌事項
- タイトル別名
-
- Antigen-specific therapy in myasthena gravis.
- アセチルコリン受容体合成ペプチドの病的免疫原性検定とその臨床応用
この論文をさがす
抄録
Based on the availability of amino acid sequence of Torpedo acetylcholine receptor, the segment α 183-200 was synthesized and used for an antigen-specific therapy in myasthenia gravis. This synthetic peptide was confirmed to be immunogenic in the induction of the animal model of immunopharmacological blokade and also antigenic in the detection of antibody in human myasthenic sera. Two patients, who had high titers of anti-peptide antibody, were treated with the plasmaperfusion by use of the peptide-bound adsorbent on 2 consecutive days. This treatment specaficically reduced the corresponding anti-peptide antibody, and also provided an improvement for myasthhnic state as estimated by electrophysioloic parameters of neuromusular transmission.
収録刊行物
-
- 人工臓器
-
人工臓器 18 (1), 19-23, 1989
一般社団法人 日本人工臓器学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679936937088
-
- NII論文ID
- 130001734006
-
- ISSN
- 18836097
- 03000818
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可